Edition:
United Kingdom

MediciNova Inc (MNOV.OQ)

MNOV.OQ on NASDAQ Stock Exchange Global Market

8.53USD
7:21pm BST
Change (% chg)

$0.04 (+0.47%)
Prev Close
$8.49
Open
$8.53
Day's High
$8.55
Day's Low
$8.35
Volume
7,035
Avg. Vol
63,186
52-wk High
$14.50
52-wk Low
$4.40

Select another date:

Tue, May 8 2018

BRIEF-MediciNova to collaborate with UCLA researchers in grant-funded clinical trial of MN-166 (ibudilast) in alcohol use disorder and withdrawal

* Says it plans to initiate a clinical trial of MN-166 (ibudilast) in alcohol dependence and withdrawal in collaboration with researchers at the University of California, Los Angeles (UCLA)

BRIEF-MediciNova Announces Proposed Underwritten Public Offering

* MEDICINOVA ANNOUNCES PROPOSED UNDERWRITTEN PUBLIC OFFERING OF COMMON STOCK

BRIEF-Medicinova Announces Phase 2B Trial results in MN-166 (Ibudilast)

* MEDICINOVA ANNOUNCES MN-166 (IBUDILAST) DEMONSTRATED A 26 PCT REDUCTION IN CONFIRMED DISABILITY PROGRESSION IN THE SPRINT-MS PHASE 2B TRIAL IN PROGRESSIVE MS: POTENTIAL BEST-IN-DISEASE DRUG Source text for Eikon: Further company coverage:

Select another date: